Drug Approval | November 25, 2021
ICMR approves Meril’s Rapid Antigen Test kit
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
Officials from ACG signed the MoU with the Maharashtra government for the Rs 600 crore investment in the backward region of Marathwada
State-of-the-art R&D facility designed to foster collaboration across world-class science ecosystem
Jardiance is the first SGLT2-inhibitor therapy to prove reduction in risk of cardiovascular death in people with type-II diabetes and established cardiovascular disease
The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis
The company is moving towards complex and more differentiated products
Premas Biotech is the developer of the technology for the Covid-19 vaccine and a shareholder in Oravax Medical
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
Vakrangee’s distribution network across rural India will help penetrate underserved markets
Subscribe To Our Newsletter & Stay Updated
